223 related articles for article (PubMed ID: 35579445)
1. Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Sun HY; Liu WD; Wang CW; Wei YJ; Lin KY; Huang YS; Su LH; Chen YT; Liu WC; Su YC; Chen YW; Chuang YC; Lu PL; Hung CC; Yu ML
Microbiol Spectr; 2022 Jun; 10(3):e0034522. PubMed ID: 35579445
[TBL] [Abstract][Full Text] [Related]
2. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals.
Łucejko M; Tomasiewicz K; Olczak A; Tudrujek-Zdunek M; Halota W; Jelski W; Donica H; Krintus M; Mroczko B; Flisiak R
Br J Biomed Sci; 2019 Oct; 76(4):190-194. PubMed ID: 31401936
[No Abstract] [Full Text] [Related]
4. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.
Mohamed Z; Mbwambo J; Shimakawa Y; Poiteau L; Chevaliez S; Pawlotsky JM; Rwegasha J; Bhagani S; Taylor-Robinson SD; Makani J; Thursz MR; Lemoine M
J Int AIDS Soc; 2017 Sep; 20(1):21856. PubMed ID: 28953324
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.
Ponnuvel S; Fletcher GJ; Anantharam R; Varughese S; David VG; Abraham P
PLoS One; 2021; 16(4):e0250263. PubMed ID: 33886631
[TBL] [Abstract][Full Text] [Related]
7. Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: A study from India.
Kumbhar N; Ramachandran K; Kumar G; Rao Pasupuleti SS; Sharma MK; Gupta E
Indian J Med Microbiol; 2021; 39(4):462-466. PubMed ID: 34294505
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals.
Sepúlveda-Crespo D; Treviño-Nakoura A; Bellon JM; Ardizone Jiménez B; Jiménez-Sousa MA; Fernández-Rodríguez A; Martínez I; Resino S
Aliment Pharmacol Ther; 2022 Oct; 56(8):1224-1234. PubMed ID: 36031747
[TBL] [Abstract][Full Text] [Related]
9. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C;
Clin Infect Dis; 2023 Feb; 76(3):e607-e612. PubMed ID: 36004410
[TBL] [Abstract][Full Text] [Related]
10. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
[TBL] [Abstract][Full Text] [Related]
11. Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations.
Sun HY; Chiang C; Huang SH; Guo WJ; Chuang YC; Huang YC; Yang CJ; Su LH; Chen YT; Chen YW; Hsu FC; Ho SY; Liu WC; Su YC; Chang SY; Hsiao CF; Hung CC; Yu ML
Microbiol Spectr; 2022 Jun; 10(3):e0243721. PubMed ID: 35499354
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam.
Nguyen TT; Lemee V; Bollore K; Vu HV; Lacombe K; Thi XLT; Luong QA; Dubos C; Plantier JC; Thi HD; Laureillard D; Lemoine M; Tuaillon E
BMC Infect Dis; 2018 Dec; 18(1):622. PubMed ID: 30514229
[TBL] [Abstract][Full Text] [Related]
13. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.
Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M
J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795
[TBL] [Abstract][Full Text] [Related]
14. Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population.
Naveed A; Khalid A; Janjua N; Cloherty GA; Akhter S
J Viral Hepat; 2024 Jun; 31(6):320-323. PubMed ID: 38483043
[TBL] [Abstract][Full Text] [Related]
15. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
[TBL] [Abstract][Full Text] [Related]
16. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.
Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV;
Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders.
Talal AH; Chen Y; Zeremski M; Zavala R; Sylvester C; Kuhns M; Brown LS; Markatou M; Cloherty GA
J Subst Abuse Treat; 2017 Jul; 78():37-42. PubMed ID: 28554601
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples.
Lamoury FMJ; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty G; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL
J Mol Diagn; 2018 Sep; 20(5):621-627. PubMed ID: 29959023
[TBL] [Abstract][Full Text] [Related]
19. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.
Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC
World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505
[TBL] [Abstract][Full Text] [Related]
20. Correlation analysis of hepatitis C virus core antigen and low viral loads: Can core antigen replace nucleic acid test?
Feng B; Yang RF; Jiang HJ; Xie YD; Zhang HY; Jin Q; Cong X; Wei L
Clin Exp Med; 2020 Feb; 20(1):131-141. PubMed ID: 31664538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
